June 26, 2024 at 11:27 am

Agile Therapeutics Tops PRISM MarketView Women’s Health Index on Merger News

Shares in the women’s healthcare company, Agile Therapeutics (OTC: AGRX), surged by more than 320% in morning trading on Wednesday after the company announced it had entered a definitive merger agreement with Insud Pharma, a global pharmaceutical group based in Spain with a 45 year track record and a presence in over 50 countries. Under… [Read More]
June 26, 2024 at 10:30 am

ANEW Medical, Inc. Shares Soar 147% Premarket on Key European Patent Win

ANEW Medical, Inc. (NASDAQ: WENA) a biopharmaceutical company specializing in the advancement of novel disease-modifying therapies for neurological and age-related disorders, experienced a 147% surge in premarket shares. The spike followed the announcement of a new European patent for its secreted Klotho gene therapy aimed at treating cognitive decline and neurodegenerative diseases.  Highlights: Strategic Intellectual… [Read More]
June 25, 2024 at 3:57 pm

German Ganja Growth: Organigram (OGI) to Capitalize on German Cannabis Market Through Investment with Sanity Group

The licensed leading producer of cannabis, Organigram Holdings Inc. (OGI), announced its first significant strategic investment aimed at expanding its presence in the European cannabis market. A contributor to the PRISM Emerging Cannabis Index, the stock is up ~13% YTD. Using proceeds from its Jupiter strategic investment pool, the Company will invest €14 million (~C$21… [Read More]
June 25, 2024 at 3:15 pm

BlackBerry (BB) Notes Increase In Cyberattacks Fueled By Politically Charged Global Environment

PRISM NextGen Tech and AI Index company, BlackBerry Limited (NYSE: BB; TSX: BB) has released an announcement regarding its latest Global Threat Intelligence Report, revealing that its cybersecurity solutions detected and prevented 3.1 million cyberattacks (an average of 37,000 per day) in the first quarter of 2024. Between January and March 2024, BlackBerry identified 630,000… [Read More]
June 25, 2024 at 1:35 pm

Eli Lilly to Collaborate with Open AI to Tackle Antimicrobial Resistance

Antimicrobial resistance (AMR) is currently one of the greatest threats to public health globally. Eli Lilly (NYSE: LLY)has announced that it will collaborate with the artificial intelligence research company, OpenAI, to use generative AI to invent novel antimicrobials to treat drug-resistant pathogens. Diogo Rau, executive vice president and chief information and digital officer at Lilly,… [Read More]
June 25, 2024 at 11:21 am

Soligenix’s HyBryte™ Exceeds Safety and Efficacy of Standard of Care in 12-Week Treatment Study

Late-stage biopharmaceutical company, Soligenix, Inc (Nasdaq: SNGX), has announced positive clinical results from a 12-week study of its lead product candidate, HyBryte™ (synthetic hypericin), which has previously been evaluated in a successful Phase 3 FLASH clinical trial in the treatment of cutaneous T-cell lymphoma (CTCL). HyBryte™ demonstrated a more rapid and robust treatment response compared… [Read More]
June 24, 2024 at 1:02 pm

Recursion (RXRX) Shares Updated Pipeline Guidance at Download Day

Recursion (RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, gave updated pipeline guidance to investors, analysts, and other stakeholders during Download Day, Recursion’s investor and R&D day, on Monday, June 24, 2024. “Since our last Download Day, which was approximately 18 months ago, we have seen various industries increasingly embrace… [Read More]
June 24, 2024 at 12:58 pm

Altimmune Obesity Drug Provides Class-Leading Lean Mass Preservation

Clinical-stage biopharmaceutical company, Altimmune, Inc (Nasdaq: ALT) topped the PRISM Global Health Index on Monday morning after the company presented data from a 48-week Phase 2 clinical trial of pemvidutide, the company’s GLP-1/glucagon dual receptor agonist candidate, in obesity. Altimmune’s share price rose by 17.69% in morning trading following the news. Altimmune presented data that… [Read More]
June 24, 2024 at 12:48 pm

Das AI: Cerence (CRNC) and Volkswagen Introduce New AI Feature to Drivers

PRISM NextGen Tech and AI Index company and leader in AI for mobility, Cerence Inc. (CRNC), has announced that Volkswagen Group has implemented Cerence Chat Pro, an advanced automotive-grade ChatGPT integration, across its European models via a cloud update. This marks the first time this solution is available to drivers. The collaboration between Cerence and… [Read More]
June 24, 2024 at 11:13 am

Oncocyte Strengthens Leadership Team with CFO Appointment

This month, precision diagnostics company, Oncocyte Corporation (Nasdaq: OCX) further strengthened its leadership team with the appointment of leading finance executive Andrea James as Chief Financial Officer. Oncocyte has reached an exciting point in its evolution as a company, and is expecting to meet a number of critical commercial and regulatory milestones during 2024 and… [Read More]